Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
开发新型 111-In 标记 DOTA 尾加压素 II 类似物，用于靶向实体肿瘤中过度表达的 UT 受体
期刊:Biomolecules
影响因子:4.8
doi:10.3390/biom10030471
Benjamin Poret, Laurence Desrues, Marc-André Bonin, Martin Pédard, Martine Dubois, Richard Leduc, Romain Modzelewski, Pierre Decazes, Fabrice Morin, Pierre Vera, Hélène Castel, Pierre Bohn, Pierrick Gandolfo
